Brief: HBM Portfolio Company Ambrx Biopharma Raises $126 Million In IPO
June 21 (Reuters) - HBM HEALTHCARE INVESTMENTS AG HBMN.S :
* HBM PORTFOLIO COMPANY AMBRX BIOPHARMA RAISES USD 126
MILLION IN
INITIAL PUBLIC OFFERING ON NEW YORK STOCK EXCHANGE
Source text for Eikon: ID:nEQbGhw1Ha
Further company coverage: HBMN.S
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on HBM Healthcare Investments AG
See all newsSwiss stocks - Factors to watch on October 23
Brief: HBM Healthcare Investments Reports Q1 Profit CHF 238 Million
Brief: HBM Healthcare Investments Posts Profit Of CHF 272 Million
Brief: SK Capital Is Said To Near Deal For Swiss Drug Distributor Swixx That Could Value Co At About 1.5 Billion Euros- Bloomberg News
Brief: Mirum Pharmaceuticals To Acquire HBM Portfolio Company Bluejay Therapeutics